![](/img/cover-not-exists.png)
A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-α maintenance therapy or observation, in small cell lung carcinoma patients with complete responses
Diego Tummarello, Davide Mari, Francesco Graziano, Pierpaolo Isidori, Gianluigi Cetto, Felice Pasini, Antonio Santo, Riccardo CellerinoVolume:
80
Year:
1997
Language:
english
Pages:
8
DOI:
10.1002/(sici)1097-0142(19971215)80:123.0.co;2-w
File:
PDF, 109 KB
english, 1997